Boehringer, Oxford University and Cumulus to explore brain activity in BPD
Boehringer Ingelheim, the University of Oxford and Cumulus Neuroscience have launched a study to monitor brain activity in individuals with…
All articles by
-
-
FDA approves AbbVie’s upadacitinib for giant cell arteritis
The US Food and Drug Administration (FDA) has granted approval for AbbVie’s 15mg Rinvoq (upadacitinib) to treat adults with giant…
-
Construction begins on MSD’s $1bn biologics centre in Delaware, US
Merck & Co (MSD) has begun construction on a $1bn biologics centre of excellence, Merck Wilmington Biotech, in Delaware, US.…
-
UK MHRA authorises BridgeBio’s acoramidis for ATTR-CM
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation for BridgeBio Pharma’s acoramidis under the name…
-
Prilenia and Ferrer to commercialise pridopidine in Europe
Prilenia Therapeutics has signed a partnership and licence agreement with Ferrer to jointly develop and commercialise pridopidine in Europe and…
-
EC conditionally approves Regeneron’s Lynozyfic for multiple myeloma
The European Commission (EC) has granted conditional marketing approval to Regeneron Pharmaceuticals’ bispecific antibody Lynozyfic (linvoseltamab) for adults with relapsed…
-
J&J’s Tremfya gains EC marketing authorisation for ulcerative colitis
The European Commission (EC) has granted marketing authorisation for Johnson & Johnson's (J&J) Tremfya (guselkumab) to treat adults with moderately…
-
Amgen to invest $900m in Ohio manufacturing facility
Amgen has announced a significant expansion of a manufacturing facility in the US state of Ohio, with an investment of…
-
China approves InnoCare Pharma’s BTK inhibitor for lymphoma
China’s National Medical Products Administration (NMPA) has approved InnoCare Pharma’s Bruton's tyrosine kinase (BTK) inhibitor orelabrutinib for use as a…
-
FDA approves Akeso’s monoclonal antibody for nasopharyngeal carcinoma
The US Food and Drug Administration (FDA) has granted approval to Akeso's differentiated programmed cell death protein 1 (PD-1) monoclonal…